FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA notes a supplemental application for VIIBRYD (vilazodone hydrochloride) submitted by Allergan, Inc., related to the existing NDA for vilazodone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Viibryd (vilazodone)

Snippet

SUPPL AP for VIIBRYD (VILAZODONE HYDROCHLORIDE)